Literature DB >> 27028604

Infection site is predictive of outcome in acute lung injury associated with severe sepsis and septic shock.

Seitaro Fujishima1, Satoshi Gando2, Saitoh Daizoh3, Shigeki Kushimoto4, Hiroshi Ogura5, Toshihiko Mayumi6, Kiyotsugu Takuma7, Joji Kotani8, Norio Yamashita9, Ryosuke Tsuruta10, Naoshi Takeyama11, Shin-Ichiro Shiraishi12, Tsunetoshi Araki13, Koichiro Suzuki14, Hiroto Ikeda15, Yasuo Miki16, Yasushi Suzuki17, Yoshihiro Yamaguchi18, Naoki Aikawa19.   

Abstract

BACKGROUND AND
OBJECTIVE: Sepsis is a leading cause of acute lung injury (ALI); however, the characteristics and outcome of sepsis-associated ALI are poorly understood. We aimed to elucidate factors that predict patient outcome in sepsis-associated ALI.
METHODS: Secondary analysis of a multicenter, prospective, observational study was performed.
RESULTS: Among 624 patients with severe sepsis and septic shock, 251 (40.2%) fulfilled the definition of American-European Consensus Conference definition of ALI. All-cause 28-day and in-hospital mortalities were 30.7% and 38.6%, respectively. More than 40% of ALI patients had neurological, cardiovascular and haematological dysfunctions or disseminated intravascular coagulation, all of which were associated with higher mortality. We report a significant correlation between infection site and mortality in patients with ALI, but not in those without ALI. The proportion of ALI was significantly higher in pulmonary sepsis; further, a complication of ALI was associated with higher mortality in sepsis from pulmonary and other sources, but not in abdominal sepsis. Among the other sepsis sites, urinary tract, central nervous system, catheter-related and undetermined foci of infection had worse outcomes when associated with ALI. None of the individual severe sepsis bundles, including fluid resuscitation and early antibiotic administration, correlated with mortality. Compliance with a set of sepsis management bundles was associated with better outcomes.
CONCLUSION: In severe sepsis and septic shock, the proportion and effect on outcome was not uniform among infection sites. The infection site was predictive of outcome in patients with ALI but not in those without ALI.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  acute lung injury; acute respiratory distress syndrome; disseminated intravascular coagulation; multiple organ dysfunction syndrome; severe sepsis

Mesh:

Year:  2016        PMID: 27028604     DOI: 10.1111/resp.12769

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  15 in total

Review 1.  Year in review 2016: Respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology.

Authors:  Marcos I Restrepo; James D Chalmers; Yuanlin Song; Christopher Mallow; Justin Hewlett; Fabien Maldonado; Lonny Yarmus
Journal:  Respirology       Date:  2017-02-28       Impact factor: 6.424

2.  microRNA-1246 mediates lipopolysaccharide-induced pulmonary endothelial cell apoptosis and acute lung injury by targeting angiotensin-converting enzyme 2.

Authors:  Yue Fang; Fengying Gao; Jing Hao; Zhenwei Liu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

3.  Spectroscopy detects skeletal muscle microvascular dysfunction during onset of sepsis in a rat fecal peritonitis model.

Authors:  Paulina M Kowalewska; Justin E Piazza; Stephanie L Milkovich; Richard J Sové; Lin Wang; Shawn N Whitehead; Christopher G Ellis
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

Review 4.  Organ dysfunction as a new standard for defining sepsis.

Authors:  Seitaro Fujishima
Journal:  Inflamm Regen       Date:  2016-11-15

5.  Evaluation of LPS-Induced Acute Lung Injury Attenuation in Rats by Aminothiazole-Paeonol Derivatives.

Authors:  Pin-Kuei Fu; Chi-Yu Yang; Su-Chin Huang; Yu-Wen Hung; Kee-Ching Jeng; Ying-Pei Huang; Hong Chuang; Nai-Chun Huang; Jui-Ping Li; Ming-Hua Hsu; Jen-Kun Chen
Journal:  Molecules       Date:  2017-09-25       Impact factor: 4.411

6.  Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.

Authors:  Bao Q Wang; Meng Shi; Jian P Zhang; Xie Wu; Mei J Chang; Zhi H Chen; Hua H Shen; Yuan L Song; Jian Zhou; Chun X Bai
Journal:  Shock       Date:  2019-02       Impact factor: 3.454

Review 7.  Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target.

Authors:  Livia Salmi; Francesco Gavelli; Filippo Patrucco; Marina Caputo; Gian Carlo Avanzi; Luigi Mario Castello
Journal:  Dis Markers       Date:  2019-08-14       Impact factor: 3.434

8.  Noninvasive ventilation failure in patients with hypoxemic respiratory failure: the role of sepsis and septic shock.

Authors:  Jun Duan; Lijuan Chen; Guopeng Liang; Weiwei Shu; Liucun Li; Ke Wang; Shengyu Wang; Xiaoyi Liu; Chunfeng He; Dehua He; Qimin Chen; Bilin Wei; Baixu Chen; Yuzhen Shu; Yao Tian; Liping Fan; Xiaoli Han; Rui Zhang; Xiangmei Yang; Yan Peng; Dong Wan; Xiaoying Chen; Lin Ye; Shijing Tian; Qiong Huang; Lei Jiang; Linfu Bai; Lintong Zhou
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

9.  Risk modifiers of acute respiratory distress syndrome in patients with non-pulmonary sepsis: a retrospective analysis of the FORECAST study.

Authors:  Hiroki Iriyama; Toshikazu Abe; Shigeki Kushimoto; Seitaro Fujishima; Hiroshi Ogura; Atsushi Shiraishi; Daizoh Saitoh; Toshihiko Mayumi; Toshio Naito; Akira Komori; Toru Hifumi; Yasukazu Shiino; Taka-Aki Nakada; Takehiko Tarui; Yasuhiro Otomo; Kohji Okamoto; Yutaka Umemura; Joji Kotani; Yuichiro Sakamoto; Junichi Sasaki; Shin-Ichiro Shiraishi; Kiyotsugu Takuma; Ryosuke Tsuruta; Akiyoshi Hagiwara; Kazuma Yamakawa; Tomohiko Masuno; Naoshi Takeyama; Norio Yamashita; Hiroto Ikeda; Masashi Ueyama; Satoshi Fujimi; Satoshi Gando
Journal:  J Intensive Care       Date:  2020-01-10

Review 10.  Organ Dysfunction in Sepsis: An Ominous Trajectory From Infection To Death.

Authors:  César Caraballo; Fabián Jaimes
Journal:  Yale J Biol Med       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.